Intended for healthcare professional education

Johnson & Johnson Institute

Total abdominal hysterectomy

Steven McCarus, MD

Procedure overview

Hysterectomy options exist for benign diseases with the route of hysterectomy influenced by several factors. A variety of surgical approaches exist for the removal of the uterus, including vaginal, abdominal, or minimally invasive. The size and shape of the uterus, and the indication for removal determine the most optimal approach for the patient. An abdominal hysterectomy is an operation to remove the uterus and cervix with or without the ovaries and fallopian tubes via the abdominal route. This abdominal laparotomy approach requires opening the abdominal wall for tissue removal. 

Indications & objectives

Abdominal hysterectomy may be done for different reasons, including, but not limited to:

  • Uterine fibroids that cause bothersome pressure, bleeding, or other problems
  • Abnormal uterine bleeding
  • Ovarian and tubal disease
  • Endometriosis
  • Pelvic adhesive disease

References

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.


Steven McCarus, MD prepared this procedure guide on behalf of Johnson & Johnson and its affiliates. The procedure guide reflects the opinions of the individual presenter, and the steps described may not encompass the complete steps of the procedure. Additionally, other surgeons may prefer different techniques, approaches, etc., as individual surgeon experience in his/her clinical practice, as well as patient needs, may dictate variation in procedure steps.


Before using any medical device, review all labeling, including without limitation; the Instructions For Use (IFU), and relevant package inserts with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device(s).


This presentation is not accredited for CE/CME.

Steven McCarus, MD is compensated by and presenting on behalf of Johnson & Johnson and its affiliates and must present information in accordance with applicable regulatory requirements.

US_ETH_ENER_219034